Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing because of cell cooperation, not just because of aging cells.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Afatinib often causes skin problems that need proactive management.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Nilotinib can cause keratosis pilaris, a skin condition.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Blocking mTORC1 reduces skin tumor growth in mice.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.